Logo image of EPRB.MI

EPRCOMUNICAZIONE SPA SOCIETA (EPRB.MI) Stock Fundamental Analysis

BIT:EPRB - Euronext Milan - IT0005519837 - Common Stock - Currency: EUR

1.11  -0.32 (-22.38%)

Fundamental Rating

3

Taking everything into account, EPRB scores 3 out of 10 in our fundamental rating. EPRB was compared to 0 industry peers in the Unkown industry. Both the profitability and financial health of EPRB have multiple concerns. EPRB is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

EPRB had negative earnings in the past year.
EPRB.MI Yearly Net Income VS EBIT VS OCF VS FCFEPRB.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 0 200K -200K 400K -400K

1.2 Ratios

Industry RankSector Rank
ROA -2.14%
ROE -5.39%
ROIC 7.21%
ROA(3y)0.08%
ROA(5y)N/A
ROE(3y)0.94%
ROE(5y)N/A
ROIC(3y)7.69%
ROIC(5y)N/A
EPRB.MI Yearly ROA, ROE, ROICEPRB.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 0 5 10 15

1.3 Margins

EPRB's Operating Margin has declined in the last couple of years.
In the last couple of years the Gross Margin of EPRB has grown nicely.
Industry RankSector Rank
OM 4.94%
PM (TTM) N/A
GM 99.78%
OM growth 3Y-1.86%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y24.32%
GM growth 5YN/A
EPRB.MI Yearly Profit, Operating, Gross MarginsEPRB.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 0 20 40 60 80

3

2. Health

2.1 Basic Checks

EPRB has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, EPRB has about the same amount of shares outstanding.
EPRB has a better debt/assets ratio than last year.
EPRB.MI Yearly Shares OutstandingEPRB.MI Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 500K 1M 1.5M 2M 2.5M
EPRB.MI Yearly Total Debt VS Total AssetsEPRB.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2M 4M 6M 8M

2.2 Solvency

An Altman-Z score of 1.83 indicates that EPRB is not a great score, but indicates only limited risk for bankruptcy at the moment.
A Debt/Equity ratio of 0.17 indicates that EPRB is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF N/A
Altman-Z 1.83
ROIC/WACC0.87
WACC8.3%
EPRB.MI Yearly LT Debt VS Equity VS FCFEPRB.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 0 1M 2M 3M

2.3 Liquidity

A Current Ratio of 1.25 indicates that EPRB should not have too much problems paying its short term obligations.
A Quick Ratio of 1.25 indicates that EPRB should not have too much problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 1.25
Quick Ratio 1.25
EPRB.MI Yearly Current Assets VS Current LiabilitesEPRB.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 1M 2M 3M 4M 5M

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 11.57% over the past year.
Looking at the last year, EPRB shows a very strong growth in Revenue. The Revenue has grown by 20.82%.
EPRB shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 29.60% yearly.
EPS 1Y (TTM)11.57%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-9.33%
Revenue 1Y (TTM)20.82%
Revenue growth 3Y29.6%
Revenue growth 5YN/A
Sales Q2Q%-14.16%

3.2 Future

Based on estimates for the next years, EPRB will show a very strong growth in Earnings Per Share. The EPS will grow by 25.56% on average per year.
The Revenue is expected to grow by 14.01% on average over the next years. This is quite good.
EPS Next Y28%
EPS Next 2Y27.87%
EPS Next 3Y25.56%
EPS Next 5YN/A
Revenue Next Year13.27%
Revenue Next 2Y15.73%
Revenue Next 3Y14.01%
Revenue Next 5YN/A

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
EPRB.MI Yearly Revenue VS EstimatesEPRB.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 5M 10M
EPRB.MI Yearly EPS VS EstimatesEPRB.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 0.1 0.2 0.3 0.4 0.5

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for EPRB. In the last year negative earnings were reported.
With a Price/Forward Earnings ratio of 2.66, the valuation of EPRB can be described as very cheap.
EPRB is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.10, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 2.66
EPRB.MI Price Earnings VS Forward Price EarningsEPRB.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
EPRB.MI Per share dataEPRB.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3

4.3 Compensation for Growth

EPRB's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
EPRB's earnings are expected to grow with 25.56% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y27.87%
EPS Next 3Y25.56%

0

5. Dividend

5.1 Amount

No dividends for EPRB!.
Industry RankSector Rank
Dividend Yield N/A

EPRCOMUNICAZIONE SPA SOCIETA

BIT:EPRB (3/3/2025, 7:00:00 PM)

1.11

-0.32 (-22.38%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.56%
Inst Owner ChangeN/A
Ins Owners7.13%
Ins Owner ChangeN/A
Market Cap3.11M
Analysts82.86
Price Target2.91 (162.16%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 2.66
P/S 0.36
P/FCF N/A
P/OCF N/A
P/B 1
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.06
EYN/A
EPS(NY)0.42
Fwd EY37.57%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS3.05
BVpS1.12
TBVpS-0.12
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.14%
ROE -5.39%
ROCE 9.61%
ROIC 7.21%
ROICexc 8.3%
ROICexgc 91.53%
OM 4.94%
PM (TTM) N/A
GM 99.78%
FCFM N/A
ROA(3y)0.08%
ROA(5y)N/A
ROE(3y)0.94%
ROE(5y)N/A
ROIC(3y)7.69%
ROIC(5y)N/A
ROICexc(3y)11.37%
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)10.26%
ROCE(5y)N/A
ROICexcg growth 3Y-45.58%
ROICexcg growth 5YN/A
ROICexc growth 3Y-29.08%
ROICexc growth 5YN/A
OM growth 3Y-1.86%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y24.32%
GM growth 5YN/A
F-ScoreN/A
Asset Turnover1.09
Health
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.25
Quick Ratio 1.25
Altman-Z 1.83
F-ScoreN/A
WACC8.3%
ROIC/WACC0.87
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)11.57%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-9.33%
EPS Next Y28%
EPS Next 2Y27.87%
EPS Next 3Y25.56%
EPS Next 5YN/A
Revenue 1Y (TTM)20.82%
Revenue growth 3Y29.6%
Revenue growth 5YN/A
Sales Q2Q%-14.16%
Revenue Next Year13.27%
Revenue Next 2Y15.73%
Revenue Next 3Y14.01%
Revenue Next 5YN/A
EBIT growth 1Y402.39%
EBIT growth 3Y27.18%
EBIT growth 5YN/A
EBIT Next Year81.82%
EBIT Next 3Y36.49%
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A